Blog
RSS FeedPosted by Michael Wonder on 05 Nov 2018
CADTH publishes initial recommendation for Tagrisso
5 November 2018 - CADTH has published its initial recommendation on the use of osimertinib mesylate for the first-line treatment ...
Posted by Michael Wonder on 05 Nov 2018
CADTH publishes initial recommendation for Lenvima
5 November 2018 - CADTH has published its initial recommendation on the use of lenvatinib mesylate in combination with everolimus ...
Posted by Michael Wonder on 17 Aug 2018
Hundreds of cancer patients received partial doses of medication
16 August 2018 - Hundreds of cancer patients in Canada did not receive the full dose of three highly concentrated ...
Posted by Michael Wonder on 08 Jul 2018
CADTH publishes initial pERC recommendation for Roche's alectinib hydrochloride
6 July 2018 - The outcome relates to the use of alectinib hydrochloride (Alecensaro) for the first-line treatment of patients ...
Posted by Michael Wonder on 21 Jun 2018
Whistler woman forced to fundraise for cancer drugs
21 June 2018 - Joni Denroche staying positive after insurance fails to cover needed treatment. ...
Posted by Michael Wonder on 04 Jun 2018
Same cancer, worse results and twice the cost in the US
1 June 2018 - Americans paid twice as much as Canadians for health care, but they didn't get twice the ...
Posted by Michael Wonder on 21 May 2018
Give paediatric cancer sufferers the help they need
21 May 2018 - Her necklace has 650 beads, one for each medical procedure she has been through. ...
Posted by Michael Wonder on 17 May 2018
This 12-year-old leukaemia survivor is fighting for equal access to medicine for all Canadians
17 May 2018 - Helena Kirk, a 12-year-old leukaemia survivor, helped spearhead a proposal to the Minister of Health with support ...
Posted by Michael Wonder on 02 May 2018
Ontario NDP promise take-home cancer drug coverage ahead of election
30 April 2018 - NDP Leader Andrea Horwath is promising universal access to take-home cancer drugs if her party wins ...
Posted by Michael Wonder on 17 Apr 2018
Governments must speed up access to approved cancer drugs
16 April 2018 - Strides in cancer research have increased survival rates and provided a better quality of life for ...
Posted by Michael Wonder on 11 Mar 2018
The relative importance of clinical, economic, patient values and feasibility criteria in cancer drug reimbursement in Canada: a revealed preferences analysis of recommendations of the pan-Canadian Oncology Drug Review 2011–2017
20 January 2018 - Most Canadian provinces and territories rely on the pan-Canadian Oncology Drug Review to provide recommendations regarding public ...
Posted by Michael Wonder on 28 Feb 2018
Digby, N.S., dad obtains high-priced drug to fight rare cancer
25 February 2018 - 'My immediate response is a big sigh of relief. It's a huge stress lifted,' says Jordan Morgan. ...
Posted by Michael Wonder on 16 Feb 2018
Quebec and New Brunswick become first provinces to provide public funding of Ibrance for the first-line treatment of metastatic breast cancer
15 February 2018 - Since Ibrance received Health Canada marketing authorisation in March 2016, Canadian women living with metastatic breast cancer ...
Posted by Michael Wonder on 25 Jan 2018
Pricey drug could help Digby dad fighting rare cancer
25 January 2018 - Jordan Morgan diagnosed with undifferentiated cell sarcoma 4 years ago. ...
Posted by Michael Wonder on 21 Jan 2018
At $262.40 per pill, the cancer drug that could save her life isn’t covered in B.C.
19 January 2018 - Karen McLaren of Langley has stage four breast cancer, and has been prescribed a drug that could ...